Cite

HARVARD Citation

    Dumitrescu, G. et al. (2015). The outcome of infliximab dose doubling in 157 patients with ulcerative colitis after loss of response to infliximab. Alimentary pharmacology & therapeutics. 42 (10), pp. 1192-1199. [Online]. 
  
Back to record